Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 6.58M | $ 4.55M | 69.15% |
3/31/2025 | $ 7.57M | $ 7.01M | 92.59% |
12/31/2024 | $ 7.14M | $ 8.93M | 125.11% |
9/30/2024 | $ 8.69M | $ 10.18M | 117.15% |
6/30/2024 | $ 11M | $ 12.02M | 109.32% |
3/31/2024 | $ 16.94M | $ 13.72M | 81.01% |
12/31/2023 | $ 20.97M | $ 13.73M | 65.48% |
9/30/2023 | $ 21.23M | $ 13.93M | 65.63% |
6/30/2023 | $ 27.17M | $ 14.17M | 52.15% |
3/31/2023 | $ 43.24M | $ 15.38M | 35.57% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for TVARDI THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 14.16M ] / Revenues [ $ 27.5M ]
(=) SB Comp % [ 51.47% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |